TY - JOUR
T1 - Persistence, Severity, and Reactivity Thresholds in Fish-Allergic Patients Sensitized to Parvalbumin
AU - Vera-Berrios, Rosialzira Natasha
AU - Vázquez-Cortés, Sonia
AU - Gonzalo-Fernández, Alejandro
AU - Bindslev-Jensen, Carsten
AU - Clausen, Michael
AU - Ferrara, Rosa
AU - Gunnbjornsdottir, Maria
AU - Jongejan, Laurian
AU - Lewandowska-Polak, Anna
AU - Mari, Adriano
AU - Papadopoulos, Nikolaos G.
AU - Poulsen, Lars K.
AU - Prado, Náyade del
AU - Santos-Magadán, Sara
AU - Schnoor, Heidi
AU - Stavroulakis, George
AU - Versteeg, Serge A.
AU - Witten, Marianne
AU - van Ree, Ronald
AU - Fernández-Rivas, Montserrat
PY - 2025/4
Y1 - 2025/4
N2 - Background: Fish allergy affects children and adults worldwide, and there are transient and persistent phenotypes. Objective: We aimed to analyze persistence, severity, and reactivity thresholds in challenge-confirmed fish-allergic patients sensitized to parvalbumin. Methods: Patients 12 to 65 years old reporting immediate reactions to fish, with fish skin prick test ≥5 mm and IgE to cod and carp β-parvalbumins ≥0.70 kUA/L, were recruited in 6 European centers. Except for the case with recent severe anaphylaxis, patients were eligible for a double-blind placebo-controlled food challenge with cod, followed, if negative, by an open food challenge. Severity of reported and elicited reactions was graded with the Food Allergy Severity Score, eliciting dose (ED) was calculated using interval-censoring survival analysis and probabilistic models, and factors associated with a positive challenge and severe reactions were analyzed by logistic regression. Results: Of 42 patients fulfilling inclusion criteria, fish allergy was confirmed in 30 (71.4%) patients. The median fish allergy duration was 23 years. Although 70% of cases reported anaphylaxis with respiratory or cardiovascular involvement, food challenges resulted in oropharyngeal symptoms (34.7%) or mild systemic reactions (73.9%), with only 1 anaphylaxis with bronchospasm (4.3%). Male sex was associated with severe reactions (odds ratio: 5.44, 95% confidence interval: 1.04-28.53). ED10 for objective symptoms was 0.99 to 2.54 mg of protein. No correlation was found between severity and ED. Conclusions: Adolescents and adults with persistent fish allergy linked to parvalbumin sensitization have experienced severe allergic reactions in real life and have a low threshold of reactivity. Our findings support the need for large-scale studies and new therapeutic options for these fish-allergic patients.
AB - Background: Fish allergy affects children and adults worldwide, and there are transient and persistent phenotypes. Objective: We aimed to analyze persistence, severity, and reactivity thresholds in challenge-confirmed fish-allergic patients sensitized to parvalbumin. Methods: Patients 12 to 65 years old reporting immediate reactions to fish, with fish skin prick test ≥5 mm and IgE to cod and carp β-parvalbumins ≥0.70 kUA/L, were recruited in 6 European centers. Except for the case with recent severe anaphylaxis, patients were eligible for a double-blind placebo-controlled food challenge with cod, followed, if negative, by an open food challenge. Severity of reported and elicited reactions was graded with the Food Allergy Severity Score, eliciting dose (ED) was calculated using interval-censoring survival analysis and probabilistic models, and factors associated with a positive challenge and severe reactions were analyzed by logistic regression. Results: Of 42 patients fulfilling inclusion criteria, fish allergy was confirmed in 30 (71.4%) patients. The median fish allergy duration was 23 years. Although 70% of cases reported anaphylaxis with respiratory or cardiovascular involvement, food challenges resulted in oropharyngeal symptoms (34.7%) or mild systemic reactions (73.9%), with only 1 anaphylaxis with bronchospasm (4.3%). Male sex was associated with severe reactions (odds ratio: 5.44, 95% confidence interval: 1.04-28.53). ED10 for objective symptoms was 0.99 to 2.54 mg of protein. No correlation was found between severity and ED. Conclusions: Adolescents and adults with persistent fish allergy linked to parvalbumin sensitization have experienced severe allergic reactions in real life and have a low threshold of reactivity. Our findings support the need for large-scale studies and new therapeutic options for these fish-allergic patients.
KW - Double-blind placebo-controlled food challenge
KW - Fish allergy
KW - Parvalbumin
KW - Severity: Threshold
U2 - 10.1016/j.jaip.2024.12.026
DO - 10.1016/j.jaip.2024.12.026
M3 - Journal article
C2 - 39732287
AN - SCOPUS:85216723943
SN - 2213-2198
VL - 13
SP - 793-802.e8
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 4
ER -